Does Rallies show Form 4 insider transactions for OSUR?

Yes. Rallies tracks OSUR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is OSUR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OSUR. It does not provide personalized investment advice.

OSUR (OraSure Technologies Inc) Stock Analysis - Insider Trades

OraSure Technologies Inc (OSUR) is a publicly traded Healthcare sector company. As of May 21, 2026, OSUR trades at $3.07 with a market cap of $207.23M and a P/E ratio of -2.96. OSUR moved -0.65% today. Year to date, OSUR is +24.29%; over the trailing twelve months it is +9.64%. Its 52-week range spans $2.08 to $4.60. Rallies surfaces OSUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading OSUR stock inside the company?

Recent OSUR insider activity includes Boyd Steven Kyle bought 25.00K, Boyd Steven Kyle bought 25.00K, Boyd Steven Kyle bought 25.00K, McGrath Kenneth J bought 32.30K, and EGLINTON MANNER CARRIE bought 32.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

OSUR Key Metrics

Key financial metrics for OSUR
Metric	Value
Price	$3.07
Market Cap	$207.23M
P/E Ratio	-2.96
EPS	$-1.04
Dividend Yield	0.00%
52-Week High	$4.60
52-Week Low	$2.08
Volume	0
Avg Volume	0
Revenue (TTM)	$113.02M
Net Income	$-75.07M
Gross Margin	42.21%

Recent OSUR Insider Trades

Boyd Steven Kyle bought 25.00K (~$74.75K) on May 14, 2026.
Boyd Steven Kyle bought 25.00K (~$75.50K) on May 13, 2026.
Boyd Steven Kyle bought 25.00K (~$74.50K) on May 12, 2026.
McGrath Kenneth J bought 32.30K (~$94.60K) on Mar 20, 2026.
EGLINTON MANNER CARRIE bought 32.30K (~$94.60K) on Mar 20, 2026.

Latest OSUR News

OraSure Q1 revenue $27.9 million beats guidance; gross margin rises to 42.3% — May 6, 2026
OraSure Appoints AI Diagnostics Executive, Pursues Board Declassification via Altai Deal — Apr 17, 2026
OraSure Cuts SG&A 37% and Plans 2026 CT/NG, Colli-Pee Launches — Mar 17, 2026
OraSure Q4 2025 Revenue Tops Estimates on Molecular Diagnostics Strength — Feb 26, 2026
OraSure Q4 Revenue Tops Guidance, Reports $19.3M Loss, Eyes 2026 Test Launches — Feb 25, 2026

OSUR Analyst Consensus

OSUR analyst coverage data. Average price target: $0.00.

Common questions about OSUR

Who is trading OSUR stock inside the company?: Recent OSUR insider activity includes Boyd Steven Kyle bought 25.00K, Boyd Steven Kyle bought 25.00K, Boyd Steven Kyle bought 25.00K, McGrath Kenneth J bought 32.30K, and EGLINTON MANNER CARRIE bought 32.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for OSUR?: Yes. Rallies tracks OSUR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is OSUR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OSUR. It does not provide personalized investment advice.